We provide hope and empower brain tumor patients with unparalleled care, research, and education.
Start your Care
At Duke...there is HOPE!
Make a difference today!
Join the fight against brain cancer.
Angels Among Us
Angels Among Us is a celebration of life, strength, courage, and commitment. It has become a national family event. The first event in 1994 raised $27,000. The 2022 event raised more than $3 million—bringing the total to over $36 million to support brain tumor research at The Preston Robert Tisch Brain Tumor Center. Your gifts are used for brain tumor research and education and may be endowed to provide ongoing support.
Stories of Discovery
We are courageously leading the quest to conquer brain cancer!
A Precise Look at Tumor Behavior
THE TISSUE THAT MAKES UP BRAIN TUMORS is very complex. It’s not easy for scientists to look at tumor cells all at once and figure out what’s happening in the tumor. But discovering better, more precise ways to look at these cells and their genetic makeup holds promise for faster diagnoses and better treatments.
The Biology of Brain Tumors
FINDING WAYS TO UNDERSTAND BETTER THE BIOLOGY of brain tumors is key to helping scientists develop more targeted treatments and possibly, one day, a cure for brain cancer.
Collaborating for Clinical Trial Success
RESEARCHERS AT DUKE HAVE BEEN WORKING for years to harness the power of the body’s immune system to fight brain tumors. Annick Desjardins, MD, FRCPC, says the successes Duke has had so far in developing immunotherapies—treatments that boost the immune system’s ability to kill cancer— are mainly due to strong collaborations.
Eliminating Brain Tumors with an Immunotoxin
TO IMPROVE THE SURVIVAL OF PATIENTS with brain tumors, Vidya Chandramohan, Ph.D., focuses on developing bacterial toxin-based therapies for glioblastoma. Glioblastoma-targeting immunotoxins were made by fusing the D2C7 antibody that binds to proteins on most brain tumor cells and Pseudomonas bacterial toxin. The D2C7 immunotoxin was developed 30 years ago in the laboratory of Darell D. Bigner, MD, Ph.D.